• 5999 malaria professionals are enjoying the free benefits of MalariaWorld today

pregnancy

Open Access | Towards the Rational Design of a Candidate Vaccine against Pregnancy Associated Malaria: Conserved Sequences of the DBL6ε Domain of VAR2CSA

Author(s): 
Cyril Badaut, Gwladys Bertin, Tatiana Rustico, Nadine Fievet, Achille Massougbodji, Alioune Gaye, Philippe Deloron
Reference: 
PLoS ONE 5(6): e11276
Contact email: 
cbadaut@gmail.com

A new sequence approach is used to compare variable regions in sequences that have extensive segmental gene relationship. Using this approach, the VAR2CSA DBL6 domain is composed of 7 variable blocks with limited polymorphism.

Open Access | Using an Improved Phagocytosis Assay to Evaluate the Effect of HIV on Specific Antibodies to Pregnancy-Associated Malaria

Author(s): 
Ricardo Ataíde, Wina Hasang, Danny W. Wilson, James G. Beeson, Victor Mwapasa, Malcolm E. Molyneux, Steven R. Meshnick, Stephen J. Rogerson
Reference: 
PLoS ONE 5(5): e10807.
Contact email: 
sroger@unimelb.edu.au

This flow cytometry-based phagocytosis assay proved to be efficient and accurate for the measurement of Fc-receptor mediated phagocytosis-inducing antibodies in large cohorts. HIV was found to affect mainly the acquisition of antibodies to pregnancy-specific malaria in primigravidae. Further studies of the relationship between opsonising antibodies to malaria in pregnancy and HIV are indicated.

Evaluation of the Antigenic Diversity of Placenta-Binding Plasmodium falciparum Variants and the Antibody Repertoire among Pregnant Women

Author(s): 
Mirja H., Salenna R. E., et al
Reference: 
Infection and Immunity, p. 1963-1978, Vol. 78, No. 5 May 2010
Contact email: 
beeson@wehi.edu.au

The results indicate that there is limited antigenic diversity in placenta-binding isolates and may explain why immunity to malaria in pregnancy can be achieved after exposure during one pregnancy.

Malaria and stillbirth in Omdurman Maternity Hospital, Sudan

Author(s): 
Elshiekh Bader, Amel M. Alhaj, Ahmed A. Hussan, Ishag Adam
Reference: 
International Journal of Gynecology & Obstetrics, Volume 109, Issue 2, May 2010, Pages 144-146
Contact email: 
ishagadam@hotmail.com

A case-control study: Cases were women who delivered stillbirths; 2 consecutive women who delivered a live-born singleton neonate at term (37–42 weeks) per case were used as controls.

Antibodies to Chondroitin Sulfate A–Binding Infected Erythrocytes: Dynamics and Protection during Pregnancy in Women Receiving Intermittent Preventive Treatment

Author(s): 
Elizabeth H. Aitken, Bernard Mbewe, Mari Luntamo, Ken Maleta, Teija Kulmala, Marc‐James Friso, Freya J. I. Fowkes, James G. Beeson, Per Ashorn, and Stephen J. Rogerson
Reference: 
The Journal of Infectious Diseases 2010;201:1316–1325

Levels of IgG antibody to pregnancy‐specific VSAs decrease during receipt of IPTp. Antibody levels in early pregnancy did not predict clinical outcome. IPTp and decreasing malaria prevalence pose challenges for the evaluation of novel interventions for malaria during pregnancy.

Investigation of reproductive toxicity of piperaquine in mice

Author(s): 
Kevin T. Batty, Brioni R. Moore, Verity Stirling, Kenneth F. Ilett, Madhu Page-Sharp, Keith B. Shilkin, Ivo Mueller, Stephen J. Rogerson, Harin A. Karunajeewa, Timothy M.E. Davis
Reference: 
Reproductive Toxicology, Volume 29, Issue 2, April 2010, Pages 206-213
Contact email: 
Kevin.Batty@curtin.edu.au

Although we found no significant PQ toxicity, clinical data are lacking and monitoring of women and their infants for biochemical and haematological adverse effects is recommended when PQ is used in pregnancy.

Open Access | Malaria Prevention with IPTp during Pregnancy Reduces Neonatal Mortality

Author(s): 
Clara Menéndez, Azucena Bardají, Betuel Sigauque, Sergi Sanz, John J. Aponte, Samuel Mabunda, Pedro L. Alonso
Reference: 
PLoS ONE 5(2): e9438
Contact email: 
menendez@clinic.ub.es

In the global context of a reduction of under-five mortality, neonatal mortality is an increasingly relevant component of this mortality. Malaria in pregnancy may affect neonatal survival, though no strong evidence exists to support this association.

Clinical Microbiology: Alternatives for Malaria Prophylaxis During the First Trimester of Pregnancy: Our Personal View

Author(s): 
Urban Hellgren, Lars Rombo
Reference: 
Journal of Travel Medicine,Volume 17, Issue 2, March/April 2010, Pages: 130-132
Contact email: 
lars.rombo@telia.com

No abstract available

High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon

Author(s): 
Marielle Karine Bouyou-Akotet, Denise Patricia Mawili-Mboumba, Tanguy de Dieu Tchantchou, and Maryvonne Kombila
Reference: 
J. Antimicrob. Chemother. 2010 65: 438-441
Contact email: 
mariellebouyou@gmail.com

These findings underline the need for a regular assessment of the relationship between the presence of resistant isolates and in vitro/in vivo IPTp/SP efficacy, and evaluation of an alternative drug.

Open Access | Case report: Congenital Plasmodium vivax malaria mimicking neonatal sepsis: a case report

Author(s): 
Veronica Del Punta, Maurizio Gulletta, Alberto Matteelli, Vania Spinoni, Antonio Regazzoli, Francesco Castelli
Reference: 
Malaria Journal 2010, 9:63 (1 March 2010)
Contact email: 
vdelpunta@libero.it

Although malaria in pregnancy can cause very significant neonatal morbidity, congenital malaria is a very rare condition in both endemic and non-endemic areas.

Syndicate content